Multicenter, randomized, controlled study to compare palonosetron plus dexamethasone before chemotherapy administration versus the same regimen on day one with dexamethasone continuing on days two and three in preventing nausea and vomiting in patients with solid tumors treated with moderately emetogenic chemotherapy

Trial Profile

Multicenter, randomized, controlled study to compare palonosetron plus dexamethasone before chemotherapy administration versus the same regimen on day one with dexamethasone continuing on days two and three in preventing nausea and vomiting in patients with solid tumors treated with moderately emetogenic chemotherapy

Completed
Phase of Trial: Phase III

Latest Information Update: 01 Aug 2011

At a glance

  • Drugs Dexamethasone; Dexamethasone; Palonosetron
  • Indications Chemotherapy-induced nausea and vomiting
  • Focus Therapeutic Use
  • Most Recent Events

    • 01 Aug 2011 Results published in Supportive Care in Cancer.
    • 02 Jun 2011 Primary endpoint 'Complete-control-of-nausea-and-vomiting' has been met.
    • 02 Jun 2011 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top